Immune checkpoint inhibitors in advanced cutaneous melanoma: a systematic review and meta-analysis of efficacy and review of characteristics-Reference-Cited by-同舟云学术

Immune checkpoint inhibitors in advanced cutaneous melanoma: a systematic review and meta-analysis of efficacy and review of characteristics

Author:

Mahdiabadi Sara¹²³⁴,Momtazmanesh Sara¹²⁴,Karimi Amirali¹,Rezaei Nima²³⁴⁵^ORCID

Affiliation:

1. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

3. Network of Dermatology Research (NDR), Universal Scientific Education and Research Network (USERN), Tehran, Iran

4. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

5. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Funder

the Tehran University of Medical Sciences

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

Reference68 articles.

4. Economic burden of toxicities associated with Treating metastatic melanoma in the United States;Bilir SP;Am Health Drug Benefits,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献